Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Concord Medical Services (NYSE:CCM) in a report issued on Saturday. The firm issued a sell rating on the stock.

Concord Medical Services Stock Performance

Concord Medical Services stock opened at $4.51 on Friday. The company has a debt-to-equity ratio of 1.15, a current ratio of 0.47 and a quick ratio of 0.46. The firm has a fifty day moving average of $4.98 and a 200-day moving average of $6.51. Concord Medical Services has a 52-week low of $3.82 and a 52-week high of $26.70.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.